Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luisa Ceccarini

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Plos One|November 8, 2012
Ion conduction through the hERG potassium channelLuisa Ceccarini, Matteo Masetti, Andrea Cavalli, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 4, 2009
hERG-related drug toxicity and models for predicting hERG liability and QT prolongationEmanuel Raschi, Luisa Ceccarini, Fabrizio De Ponti, et al.
Journal of Chemical Information and Modeling|December 25, 2012
An automated docking protocol for hERG channel blockersGiovanni Paolo Di Martino, Matteo Masetti, Luisa Ceccarini, et al.
Bioorganic & Medicinal Chemistry|February 23, 2010
Targeting Alzheimer's disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238Stefano Rizzo, Manuela Bartolini, Luisa Ceccarini, et al.
Chemmedchem|February 18, 2009
Structure-activity relationships and binding mode in the human acetylcholinesterase active site of pseudo-irreversible inhibitors related to xanthostigmineStefano Rizzo, Andrea Cavalli, Luisa Ceccarini, et al.
Journal of Medicinal Chemistry|March 30, 2012
Computational design and discovery of "minimally structured" hERG blockersAndrea Cavalli, Rosa Buonfiglio, Cristina Ianni, et al.
Journal of Medicinal Chemistry|July 9, 2008
Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rushMichela Rosini, Elena Simoni, Manuela Bartolini, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Plos One|November 8, 2012
Ion conduction through the hERG potassium channelLuisa Ceccarini, Matteo Masetti, Andrea Cavalli, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 4, 2009
hERG-related drug toxicity and models for predicting hERG liability and QT prolongationEmanuel Raschi, Luisa Ceccarini, Fabrizio De Ponti, et al.
Journal of Chemical Information and Modeling|December 25, 2012
An automated docking protocol for hERG channel blockersGiovanni Paolo Di Martino, Matteo Masetti, Luisa Ceccarini, et al.
Bioorganic & Medicinal Chemistry|February 23, 2010
Targeting Alzheimer's disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238Stefano Rizzo, Manuela Bartolini, Luisa Ceccarini, et al.
Chemmedchem|February 18, 2009
Structure-activity relationships and binding mode in the human acetylcholinesterase active site of pseudo-irreversible inhibitors related to xanthostigmineStefano Rizzo, Andrea Cavalli, Luisa Ceccarini, et al.
Journal of Medicinal Chemistry|March 30, 2012
Computational design and discovery of "minimally structured" hERG blockersAndrea Cavalli, Rosa Buonfiglio, Cristina Ianni, et al.
Journal of Medicinal Chemistry|July 9, 2008
Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rushMichela Rosini, Elena Simoni, Manuela Bartolini, et al.
Pageof 1